Published in Curr Opin Investig Drugs on June 01, 2009
Targeting stroma to treat cancers. Semin Cancer Biol (2011) 1.33
Synchronization of circadian Per2 rhythms and HSF1-BMAL1:CLOCK interaction in mouse fibroblasts after short-term heat shock pulse. PLoS One (2011) 1.09
Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine (Lond) (2011) 1.03
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia (2010) 0.97
NK cells: immune cross-talk and therapeutic implications. Immunotherapy (2011) 0.96
Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics. Clin Cancer Res (2011) 0.94
Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model. Int J Hyperthermia (2010) 0.92
Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia. Med Phys (2013) 0.89
Whole Tumor Antigen Vaccines: Where Are We? Vaccines (Basel) (2015) 0.87
Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions. Oncoscience (2014) 0.84
Fever in Cancer Treatment: Coley's Therapy and Epidemiologic Observations. Glob Adv Health Med (2012) 0.84
Interleukin-6 Induced "Acute" Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics. Theranostics (2016) 0.83
Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports. Glob Adv Health Med (2012) 0.83
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin. Clin Dev Immunol (2012) 0.80
Toward establishment of temperature thresholds for immunological impact of heat exposure in humans. Int J Hyperthermia (2011) 0.79
Protecting the normal in order to better kill the cancer. Cancer Med (2015) 0.78
Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation. Sci Rep (2016) 0.77
Culture at a Higher Temperature Mildly Inhibits Cancer Cell Growth but Enhances Chemotherapeutic Effects by Inhibiting Cell-Cell Collaboration. PLoS One (2015) 0.77
Focused ultrasound-aided immunomodulation in glioblastoma multiforme: a therapeutic concept. J Ther Ultrasound (2016) 0.77
Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy. Case Rep Oncol (2012) 0.75
Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression. PLoS One (2015) 0.75
The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth. Oncol Lett (2017) 0.75
Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) (2003) 8.04
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest (2005) 7.01
The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol (2001) 6.10
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med (2000) 5.62
Correlation between synthesis of heat shock proteins and development of thermotolerance in Chinese hamster fibroblasts. Proc Natl Acad Sci U S A (1982) 4.54
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48
Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci (2006) 4.04
Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia (2003) 3.49
Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol (2001) 3.12
High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today (1995) 2.95
Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J (1997) 2.92
Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (1997) 2.92
Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics (1994) 2.88
Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother (2005) 2.87
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J Clin Oncol (2002) 2.57
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy. J Immunother (2008) 2.57
Cancer vaccines. Nat Med (1998) 2.22
Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol (2006) 2.05
Chaperones in control of protein disaggregation. EMBO J (2008) 2.01
Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res (2007) 1.87
Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia (2005) 1.82
Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity (2004) 1.76
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol (2000) 1.72
Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hyperthermia (2008) 1.60
Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity. Immunology (2006) 1.54
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin Cancer Res (2003) 1.46
Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol (2009) 1.44
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J Immunol (2001) 1.44
Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res (2006) 1.44
Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res (2003) 1.41
Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperthermia (2008) 1.40
Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol (2000) 1.34
Concepts of fever. Arch Intern Med (1998) 1.33
Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J Immunol (2005) 1.33
Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem (2007) 1.33
Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol (2001) 1.33
Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res (2003) 1.33
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res (2000) 1.30
Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication. J Immunol (2004) 1.29
Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev Vaccines (2008) 1.19
Making room for T cells. J Clin Invest (2002) 1.19
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines. Cancer Immunol Immunother (2008) 1.18
Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol (2007) 1.18
Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res (2002) 1.15
Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol (1998) 1.15
Dynamic behavior and function of Foxp3+ regulatory T cells in tumor bearing host. Cell Mol Immunol (2009) 1.13
Heat shock co-activates interleukin-8 transcription. Am J Respir Cell Mol Biol (2008) 1.12
70 kDa heat shock cognate protein is a transformation-associated antigen and a possible target for the host's anti-tumor immunity. J Immunol (1993) 1.12
Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96. J Biol Chem (2001) 1.10
Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood (2001) 1.08
Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res (2002) 1.08
Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant (2003) 1.07
Heat shock protein derivatives for delivery of antigens to antigen presenting cells. Int J Pharm (2007) 1.06
On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen. Cancer Res (2001) 1.05
Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol (2007) 1.05
Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. J Immunol (2006) 1.05
Hyperthermia enhances CTL cross-priming. J Immunol (2006) 1.05
Heat shock proteins refine the danger theory. Immunology (2000) 1.04
Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol (1998) 1.03
Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother (2005) 1.03
Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J Cell Physiol (1997) 1.03
The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia (2008) 1.03
Fever-like temperature induces maturation of dendritic cells through induction of hsp90. Int Immunol (2003) 1.01
Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer (2005) 1.00
Host antitumour immune responses to HIFU ablation. Int J Hyperthermia (2007) 0.99
Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Res (2007) 0.99
Heat shock protein-based cancer vaccines. Expert Rev Vaccines (2004) 0.97
A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma. Dig Dis Sci (2007) 0.97
Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys (1997) 0.96
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity. Vaccine (2008) 0.96
Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol (2001) 0.95
Biological effects of heat. Cancer Res (1984) 0.95
Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110. Cancer Immunol Immunother (2006) 0.94
Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol (1991) 0.93
Tumor microvasculature as a barrier to antitumor immunity. Cancer Immunol Immunother (2003) 0.93
Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J Immunol (1999) 0.92
CXC chemokines: a new family of heat-shock proteins? Immunol Invest (2005) 0.92
Effects of a heat shock protein inhibitor KNK437 on heat sensitivity and heat tolerance in human squamous cell carcinoma cell lines differing in p53 status. Int J Radiat Biol (2004) 0.91
A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models. Int J Hyperthermia (2002) 0.91
Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int J Hyperthermia (2000) 0.91
Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia (2008) 0.91
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma. Int J Cancer (2007) 0.90
Cellular and vascular reactions in the liver to radio-frequency thermo-ablation with wet needle applicators. Study on juvenile domestic pigs. Eur Surg Res (2002) 0.89
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol (2008) 0.89
Carl Reinhold August Wunderlich and the evolution of clinical thermometry. Clin Infect Dis (1994) 0.88
Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol (2003) 0.87
The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. Int J Hyperthermia (2004) 0.85
Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer (2008) 0.85
How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia (2005) 0.85
An important role for granulocytes in the thermal regulation of colon tumor growth. Immunol Invest (2005) 0.84
Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. J Clin Endocrinol Metab (2006) 0.84
Thermal facilitation of lymphocyte trafficking involves temporal induction of intravascular ICAM-1. Microcirculation (2008) 0.83
Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. Am J Physiol Regul Integr Comp Physiol (2005) 0.83
Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol (2007) 0.83
Dendritic cells in tumor immunology and immunotherapy. Curr Drug Targets (2004) 0.82
The effect of in vivo hyperthermia on selected lymphokines in man. Lymphokine Res (1987) 0.81
Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharmacol Res (2000) 0.81
Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degrees C. Eur J Appl Physiol (2005) 0.81
RNA interference-mediated silencing of the Hsp70 gene inhibits human gastric cancer cell growth and induces apoptosis in vitro and in vivo. Tumori (2008) 0.81
Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell (2008) 3.95
Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol (2006) 2.05
Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity (2004) 1.76
Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts. Cancer Biol Ther (2009) 1.63
Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proc Natl Acad Sci U S A (2013) 1.58
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res (2002) 1.47
IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J Clin Invest (2011) 1.46
Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner. Blood (2012) 1.46
Scavenger receptor-A negatively regulates antitumor immunity. Cancer Res (2007) 1.42
The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID mice. J Transl Med (2005) 1.37
Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction (2003) 1.33
Contributions from self-renewal and trafficking to the uterine NK cell population of early pregnancy. J Immunol (2002) 1.26
HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice. J Immunol (2003) 1.23
Mutation rate of MAP2K4/MKK4 in breast carcinoma. Hum Mutat (2002) 1.21
Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease. Int J Cancer (2003) 1.13
Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity. Cancer Res (2006) 1.13
Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker. Clin Cancer Res (2008) 1.11
Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res (2011) 1.10
Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge. PLoS One (2012) 1.06
Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol (2007) 1.05
Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma. J Immunol (2006) 1.05
Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest (2006) 1.05
Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen. J Immunol (2010) 1.04
CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. J Immunol (2011) 1.04
Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother (2005) 1.03
Heat shock proteins as vaccine adjuvants in infections and cancer. Drug Discov Today (2006) 1.01
Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia. Immunol Res (2010) 0.98
Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene (2002) 0.98
Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. J Leukoc Biol (2011) 0.98
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo. J Hepatol (2011) 0.98
Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor? Int J Hyperthermia (2010) 0.97
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL. Mol Cancer Ther (2006) 0.96
IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation. J Immunol (2013) 0.96
Protocols for simulating the thermal component of fever: preclinical and clinical experience. Methods (2004) 0.94
Regulation of a lymphocyte-endothelial-IL-6 trans-signaling axis by fever-range thermal stress: hot spot of immune surveillance. Cytokine (2007) 0.94
Characterization of monocarboxylate transport in human kidney HK-2 cells. Mol Pharm (2006) 0.94
Tumor microvasculature as a barrier to antitumor immunity. Cancer Immunol Immunother (2003) 0.93
Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Int J Hyperthermia (2007) 0.92
Coordinate regulation of lymphocyte-endothelial interactions by pregnancy-associated hormones. J Immunol (2003) 0.92
Immunotherapy of cancer using heat shock proteins. Front Biosci (2002) 0.92
Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses. Int J Hyperthermia (2008) 0.91
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer Immunol Immunother (2014) 0.90
Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer? Int J Hyperthermia (2010) 0.90
Origin of the vasculature supporting growth of primary patient tumor xenografts. J Transl Med (2013) 0.90
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat (2013) 0.90
Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model. Leuk Lymphoma (2005) 0.89
Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor. Clin Colorectal Cancer (2009) 0.89
Physiological-range temperature changes modulate cognate antigen processing and presentation mediated by lipid raft-restricted ubiquitinated B cell receptor molecules. J Immunol (2010) 0.88
Water: a simple solution for tumor spillage. Ann Surg Oncol (2011) 0.87
Heat shock proteins and cancer therapy: the trail grows hotter! Oncotarget (2011) 0.87
Trafficking of circulating pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and human. Immunol Invest (2005) 0.87
A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activation. Cell Cycle (2015) 0.86
Opposing roles for heat and heat shock proteins in macrophage functions during inflammation: a function of cell activation state? Front Immunol (2012) 0.85
Dynamic control of lymphocyte trafficking by fever-range thermal stress. Cancer Immunol Immunother (2005) 0.85
Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunol Immunother (2002) 0.84
Periovulatory increases in tissue homing potential of circulating CD56(bright) cells are associated with fertile menstrual cycles. J Clin Endocrinol Metab (2005) 0.84
Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperthermia (2012) 0.84
Physiologically based pharmacokinetic models for everolimus and sorafenib in mice. Cancer Chemother Pharmacol (2013) 0.84
Nitric oxide production is regulated by fever-range thermal stimulation of murine macrophages. J Leukoc Biol (2005) 0.83
The potential of the tumor microenvironment to influence Apo2L/TRAIL induced apoptosis. Immunol Invest (2006) 0.83
VSGP/F-spondin: a new ovarian cancer marker. Tumour Biol (2005) 0.82
Kadota Fund International Forum 2004. Application of thermal stress for the improvement of health, 15-18 June 2004, Awaji Yumebutai International Conference Center, Awaji Island, Hyogo, Japan. Final report. Int J Hyperthermia (2008) 0.82
Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunol Invest (2005) 0.82
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model. J Transl Med (2007) 0.82
Fine-tuning immune surveillance by fever-range thermal stress. Immunol Res (2010) 0.82
Tumour secreted grp170 chaperones full-length protein substrates and induces an adaptive anti-tumour immune response in vivo. Int J Hyperthermia (2010) 0.81
Primary immune surveillance: some like it hot. J Mol Med (Berl) (2007) 0.81
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in mice. Cancer Chemother Pharmacol (2013) 0.81
Housing temperature influences the pattern of heat shock protein induction in mice following mild whole body hyperthermia. Int J Hyperthermia (2014) 0.81
Winner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice. Int J Hyperthermia (2008) 0.81
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy. Pancreas (2014) 0.80
Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA. Int J Hyperthermia (2013) 0.80
Mild cold-stress depresses immune responses: Implications for cancer models involving laboratory mice. Bioessays (2014) 0.80
Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity. Int J Hyperthermia (2013) 0.80
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens. Cancer Immunol Immunother (2010) 0.80
Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts. Oncology (2008) 0.79
Toward establishment of temperature thresholds for immunological impact of heat exposure in humans. Int J Hyperthermia (2011) 0.79
Conservation of IL-6 trans-signaling mechanisms controlling L-selectin adhesion by fever-range thermal stress. Eur J Immunol (2007) 0.79
The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy. Immunol Invest (2005) 0.78
Thermal regulation of lymphocyte trafficking: hot spots of the immune response. Int J Hyperthermia (2005) 0.76
Progress in development of biomedical applications of heat shock proteins and thermal stress. Int J Hyperthermia (2013) 0.76
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010. J Immunother (2010) 0.75
β2 Adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells. J Clin Invest (2019) 0.75
Dr. Joan Bull--recipient of the 2008 Robinson Award. Int J Hyperthermia (2008) 0.75
Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy. Immunol Invest (2007) 0.75